Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler A Cunningham

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Oncotarget|November 27, 2018
eIF4A inhibition: ready for primetime?Tyler A Cunningham, Eli Chapman, Jonathan H Schatz
STAR Protocols|January 3, 2023
MATRIX platform to analyze translation machinery remodeling in glioblastoma cellsJ J David Ho, Tyler A Cunningham, Jonathan R Krieger, et al.
ACS Omega|October 4, 2021
Molecular Dynamics Simulations Identify Tractable Lead-like Phenyl-Piperazine Scaffolds as eIF4A1 ATP-competitive InhibitorsDerek J Essegian, Tyler A Cunningham, Christopher J Zerio, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2014
Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief reportEva M Garrido-Martin, Ha-Long Nguyen, Tyler A Cunningham, et al.
Cell Reports|October 13, 2021
Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatomeJ J David Ho, Tyler A Cunningham, Paola Manara, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapyPaola Manara, Austin D Newsam, Venu Vg Saralamma, et al.
Journal of Medicinal Chemistry|October 22, 2021
Discovery of an eIF4A Inhibitor with a Novel Mechanism of ActionChristopher J Zerio, Tyler A Cunningham, Allison S Tulino, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Oncotarget|November 27, 2018
eIF4A inhibition: ready for primetime?Tyler A Cunningham, Eli Chapman, Jonathan H Schatz
STAR Protocols|January 3, 2023
MATRIX platform to analyze translation machinery remodeling in glioblastoma cellsJ J David Ho, Tyler A Cunningham, Jonathan R Krieger, et al.
ACS Omega|October 4, 2021
Molecular Dynamics Simulations Identify Tractable Lead-like Phenyl-Piperazine Scaffolds as eIF4A1 ATP-competitive InhibitorsDerek J Essegian, Tyler A Cunningham, Christopher J Zerio, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2014
Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief reportEva M Garrido-Martin, Ha-Long Nguyen, Tyler A Cunningham, et al.
Cell Reports|October 13, 2021
Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatomeJ J David Ho, Tyler A Cunningham, Paola Manara, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapyPaola Manara, Austin D Newsam, Venu Vg Saralamma, et al.
Journal of Medicinal Chemistry|October 22, 2021
Discovery of an eIF4A Inhibitor with a Novel Mechanism of ActionChristopher J Zerio, Tyler A Cunningham, Allison S Tulino, et al.
Pageof 1